{"id":7767,"date":"2025-02-18T12:26:16","date_gmt":"2025-02-18T07:26:16","guid":{"rendered":"https:\/\/ksestocks.com\/blog\/?p=7767"},"modified":"2025-02-18T12:27:12","modified_gmt":"2025-02-18T07:27:12","slug":"citi-pharma-cphl-trading-near-buy-range","status":"publish","type":"post","link":"https:\/\/ksestocks.com\/blog\/citi-pharma-cphl-trading-near-buy-range\/","title":{"rendered":"Citi Pharma (CPHL) trading near buy range"},"content":{"rendered":"\n<p>Citi Pharma (<strong><a href=\"https:\/\/ksestocks.com\/blog\/tag\/cphl\/\" target=\"_blank\" rel=\"noopener\" title=\"CPHL\">CPHL<\/a><\/strong>) highlights an ongoing uptrend within a structured channel, with key buying zones around PKR 92 and PKR 84. <\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img decoding=\"async\" width=\"1024\" height=\"485\" src=\"https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2025\/02\/WhatsApp-Image-2025-02-18-at-12.18.17_79c79244-1024x485.jpg\" alt=\"cphl technical analysis\" class=\"wp-image-7770\" srcset=\"https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2025\/02\/WhatsApp-Image-2025-02-18-at-12.18.17_79c79244-1024x485.jpg 1024w, https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2025\/02\/WhatsApp-Image-2025-02-18-at-12.18.17_79c79244-768x364.jpg 768w, https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2025\/02\/WhatsApp-Image-2025-02-18-at-12.18.17_79c79244-640x303.jpg 640w, https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2025\/02\/WhatsApp-Image-2025-02-18-at-12.18.17_79c79244-400x189.jpg 400w, https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2025\/02\/WhatsApp-Image-2025-02-18-at-12.18.17_79c79244-367x174.jpg 367w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p>RSI at 43.47 suggests neutral momentum, while volume trends indicate buying interest at lower levels. <\/p>\n\n\n\n<p>On the fundamental side, CPHL is positioned for growth with increasing healthcare demand, production expansion, and export\u00a0potential.<\/p>\n\n\n\n<p><strong>Disclaimer:<\/strong><\/p>\n\n\n\n<p><em>The above is just a trade idea and should not be taken as financial advice.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Citi Pharma (CPHL) highlights an ongoing uptrend within a structured channel, with key buying zones around PKR 92 and PKR 84. RSI at 43.47 suggests neutral momentum, while volume trends indicate buying interest at lower levels. On the fundamental side, CPHL is positioned for growth with increasing healthcare demand, production expansion, and export\u00a0potential. Disclaimer: The [&hellip;]<\/p>\n","protected":false},"author":9255,"featured_media":7769,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[154,127],"tags":[242],"class_list":["post-7767","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-technical-analysis","tag-cphl"],"featured_image_src":{"landsacpe":["https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2025\/02\/cphl-technical-analysis-feb-2025-1140x445.jpg",1140,445,true],"list":["https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2025\/02\/cphl-technical-analysis-feb-2025-463x348.jpg",463,348,true],"medium":["https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2025\/02\/cphl-technical-analysis-feb-2025-300x188.jpg",300,188,true],"full":["https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2025\/02\/cphl-technical-analysis-feb-2025.jpg",1920,1200,false]},"_links":{"self":[{"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/posts\/7767","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/users\/9255"}],"replies":[{"embeddable":true,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/comments?post=7767"}],"version-history":[{"count":0,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/posts\/7767\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/media\/7769"}],"wp:attachment":[{"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/media?parent=7767"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/categories?post=7767"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/tags?post=7767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}